375 related articles for article (PubMed ID: 32729451)
21. Mycoplasma hominis impacts gene expression in Trichomonas vaginalis.
Fürnkranz U; Henrich B; Walochnik J
Parasitol Res; 2018 Mar; 117(3):841-847. PubMed ID: 29368037
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of double-stranded RNA virus in Trichomonas vaginalis isolated in Italy and association with the symbiont Mycoplasma hominis.
Margarita V; Marongiu A; Diaz N; Dessì D; Fiori PL; Rappelli P
Parasitol Res; 2019 Dec; 118(12):3565-3570. PubMed ID: 31701295
[TBL] [Abstract][Full Text] [Related]
23. Genetic Indicators of Drug Resistance in the Highly Repetitive Genome of Trichomonas vaginalis.
Bradic M; Warring SD; Tooley GE; Scheid P; Secor WE; Land KM; Huang PJ; Chen TW; Lee CC; Tang P; Sullivan SA; Carlton JM
Genome Biol Evol; 2017 Jun; 9(6):1658-1672. PubMed ID: 28633446
[TBL] [Abstract][Full Text] [Related]
24. Proteomic signatures of metronidazole-resistant Trichomonas vaginalis reveal novel proteins associated with drug resistance.
Lin HC; Chu LJ; Huang PJ; Cheng WH; Zheng YH; Huang CY; Hong SW; Chen LC; Lin HA; Wang JY; Chen RM; Lin WN; Tang P; Huang KY
Parasit Vectors; 2020 Jun; 13(1):274. PubMed ID: 32487244
[TBL] [Abstract][Full Text] [Related]
25. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
Forbes GL; Drayton R; Forbes GD
Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
[TBL] [Abstract][Full Text] [Related]
26. Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010.
Kirkcaldy RD; Augostini P; Asbel LE; Bernstein KT; Kerani RP; Mettenbrink CJ; Pathela P; Schwebke JR; Secor WE; Workowski KA; Davis D; Braxton J; Weinstock HS
Emerg Infect Dis; 2012 Jun; 18(6):939-43. PubMed ID: 22608054
[TBL] [Abstract][Full Text] [Related]
27. Phase solubility studies and anti-Trichomonas vaginalis activity evaluations of metronidazole and methylated β-cyclodextrin complexes: Comparison of CRYSMEB and RAMEB.
Malli S; Bories C; Ponchel G; Loiseau PM; Bouchemal K
Exp Parasitol; 2018 Jun; 189():72-75. PubMed ID: 29730454
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.
Pérez S; Fernández-Verdugo A; Pérez F; Vázquez F
Sex Transm Dis; 2001 Feb; 28(2):115-6. PubMed ID: 11234785
[No Abstract] [Full Text] [Related]
29. In vitro activity of amixicile against T. vaginalis from clinical isolates.
Jain E; Zaenker EI; Hoffman PS; Warren CA
Parasitol Res; 2022 Aug; 121(8):2453-2455. PubMed ID: 35676563
[TBL] [Abstract][Full Text] [Related]
30. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
[TBL] [Abstract][Full Text] [Related]
31. Comparative effect of manuka honey on anaerobic parasitic protozoans with standard drug therapy under
Sinha S; Prakash A; Sehgal R; Medhi B
Indian J Pharmacol; 2018; 50(4):197-203. PubMed ID: 30505056
[TBL] [Abstract][Full Text] [Related]
32. HQSAR and random forest-based QSAR models for anti-T. vaginalis activities of nitroimidazoles derivatives.
Veríssimo GC; Menezes Dutra EF; Teotonio Dias AL; de Oliveira Fernandes P; Kronenberger T; Gomes MA; Maltarollo VG
J Mol Graph Model; 2019 Jul; 90():180-191. PubMed ID: 31100677
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity of Trichomonas vaginalis to metronidazole, tinidazole, and nifuratel in vitro.
Korner B; Jensen HK
Br J Vener Dis; 1976 Dec; 52(6):404-8. PubMed ID: 1087577
[TBL] [Abstract][Full Text] [Related]
34. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
[TBL] [Abstract][Full Text] [Related]
35. The antimicrobial peptides LL-37, KR-20, FK-13 and KR-12 inhibit the growth of a sensitive and a metronidazole-resistant strain of Trichomonas vaginalis.
Ramírez-Ledesma MG; Rodríguez MC; Alva-Murillo N; Avila EE
Parasitol Res; 2022 Dec; 121(12):3503-3512. PubMed ID: 36171407
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of in vitro development of resistance to metronidazole in Trichomonas vaginalis.
Rasoloson D; Vanacova S; Tomkova E; Razga J; Hrdy I; Tachezy J; Kulda J
Microbiology (Reading); 2002 Aug; 148(Pt 8):2467-2477. PubMed ID: 12177340
[TBL] [Abstract][Full Text] [Related]
37. Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles.
Meingassner JG; Thurner J
Antimicrob Agents Chemother; 1979 Feb; 15(2):254-7. PubMed ID: 311617
[TBL] [Abstract][Full Text] [Related]
38. In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis.
Küng E; Pietrzak J; Klaus C; Walochnik J
Int J Antimicrob Agents; 2016 Mar; 47(3):232-4. PubMed ID: 26899578
[TBL] [Abstract][Full Text] [Related]
39. Metronidazole-resistant Trichomonas vaginalis.
Forsgren A; Forssman L
Br J Vener Dis; 1979 Oct; 55(5):351-3. PubMed ID: 315809
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of flavin reductase and alcohol dehydrogenase-1 (ADH1) in metronidazole-resistant isolates of Trichomonas vaginalis.
Leitsch D; Drinić M; Kolarich D; Duchêne M
Mol Biochem Parasitol; 2012 Jun; 183(2):177-83. PubMed ID: 22449940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
